Tag: Merger

Displaying 1 - 20 of 730 results.

Pages

The Federal Trade Commission and Department of Justice today issued revised Antitrust Guidelines for International Enforcement and Cooperation.
This week, Chairwoman Edith Ramirez and FTC International Affairs staff are participating in discussions on geographic market definition, trade-offs between merger prohibition and conditional clearance,
On Monday, the FTC accepted for public comment a proposed consent order involving a consummated merger in the eye care industry. According to the complaint, Valeant Pharmaceuticals’ 2015 acquisition of Paragon Holdings reduced competition for polymer discs (aka buttons) used to make...
Valeant Pharmaceuticals, the parent of Bausch + Lomb, agreed to sell Paragon Holdings I, Inc. to settle charges that its May 2015 acquisition of Paragon reduced competition for the sale of FDA-approved buttons used for three types of gas permeable, or GP, lenses: orthokeratology...
“The FTC is pleased that the 7th Circuit rejected the district court’s geographic market findings, and we are looking forward to proving our case,” said Debbie Feinstein, Director of the FTC’s Bureau of Competition.
FTC staff submitted a comment to the Southwest Virginia Health Authority and the Virginia Department of Health opposing the cooperative agreement application submitted by Mountain States Health Alliance and Wellmont Health System. “The proposed merger presents substantial risk of...
The Federal Trade Commission has approved final amendments to the Hart-Scott-Rodino Premerger Notification Rules that allow HSR filings to be submitted on DVD and streamline the instructions to the Premerger Notification Form. These updates will make the process of submitting HSR filings easier,...
ON Semiconductor Corporation agreed to sell its Ignition IGBT business in order to settle charges that its proposed $2.4 billion acquisition of Fairchild Semiconductor International, Inc. would likely substantially lessen competition in the worldwide market for Ignition IGBTs,...
Mylan Inc. agreed to divest the rights and assets related to two generic pharmaceutical products in order to settle FTC charges that its proposed $7.2 billion acquisition of Swedish drug maker Meda would be anticompetitive. The FTC order preserves competition in the markets for 250...

Pages